Pharmaceutical Marketing Tracking ProjectBy: Chris Miller

In 1887 Luther Perrigo, the proprietor of a general store and apple-drying business, had the idea to package and distribute patented medicines and household items for country stores. Located in Allegan, Michigan, the L. Perrigo Company has grown in size and scope to become a leading global healthcare supplier that develops, manufactures and distributes over-the-counter and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.

“Providing the World with quality, affordable healthcare products”

-Luther’s Company Vision

History of Perrigo

Perrigo’s Product Categories

• Over-the-counter and generic prescription (Rx) pharmaceuticals

• Infant formulas• Nutritional products• Active pharmaceutical

ingredients (API)• Pharmaceutical and

medical diagnostic products.

Building a Global FootprintKey Acquisitions:• 1997- Quimica y Farmacia (Mexico)

• Largest retail brand pharmaceuticals in Mexico• 2001- Wrafton Laboratories Limited (U.K.)

• Largest manufacturer of OTC drugs / nutrition products • 2005- Agis Industries (Isreal)

• Developing, manufacturing, and marketing API / pharmaceuticals / medical diagnostic equipment• 2010- Orion Laboratories Pty., Ltd. (Australia & New Zealand)

• Leading supplier of OTC store brand pharmaceuticals• 2010- PBM Holdings, Inc. (U.S., Canada, Mexico, & China)

• Leading manufacturer of store-brand infant formulaKey Moves:• 2003-Perrigo India (API, Formulation R&D, Analytic R&D, Auditing)• 2003- Perrigo China (Raw Material Sourcing, and Quality Support)

• $102.28 Dec 28, 2012- Perrigo acquires remaining stake in Cobrek Pharmaceuticals, Inc. for approximately $45M (solidifies leadership in topical foam-based generic drugs)

• $109.03 Jan 7, 2013- Perrigo gains FDA clearance to manufacturer 3 Codex-Compliant Infant formulas internationally / announces launch of authorized generic version of Acetadote (acetylcysteine) Injection

• $110.23 Jan 10 - $103.85 Jan 11 - Market drop from over valuing

• $105.10 Jan 15 – Perrigo announces commercial launch of betamethasone valerate foam .12%, the generic equivalent of Luxiq® Foam, originally filed under Cobrek^

PRGO Stock Price

Dec 28 – Jan 15

• $104.00 Jan 18 – Perrigo to release its Second Quarter Fiscal Year 2013 results on Feb. 1

• $104.21 Jan 22 - Perrigo launches store brand version of Nicorette Mini Nicotine Lozenges (this launch strengthens leading store brand position in smoking cessation products)

• $101.61 Jan 24 - Perrigo partnered with Ther-Rx Corp. and announced the availability of Gynazole for prescribing (treats yeast infections)

• $103.12 Jan 25 - Perrigo Nutritionals Unveils new packaging innovation SmarTub Infant Formula Package (leading infant formula company supplying mass retailers, grocers, and drugstores with their own store brand infant formulas)

PRGO Stock Price

Jan 16– Jan 31

• $105.28 Feb 1

• Perrigo acquires Velcera Inc. for $160M, adding #1 OTC flea and tick value brand, PetArmour (positions perrigo to launch multiple veterinary quality national alternatives)

• Perrigo commences launch of Clobetasol Emulsion Propionate Foam, .05%, generic of Olux® -E Foam, 0.05% (received 180 days of generic exclusivity)

• Perrigo Reports Second Quarter Revenue, Adjusted Earnings and Operating Cash Flow (adjusted net income inc. 14%, GAAP net income inc. 6%, adjusted earnings per share inc. of ~$.70)

• $106.73 Feb 5 – Perrigo confirms FDA approval for Testosterone Gel 1%, equivalent to AbbVie's AndroGel® 1% (essentially benefiting off all of the competitor’s advertising)

• $111.53 Feb 11 – Perrigo acquires U.K. based Rosemont Pharmaceuticals for $283M (expands international presence, R&D capabilities, and Perrigo’s liquid drug line)

PRGO Stock Price

Feb 1 – Feb 15

• $114.73 Feb 19

• Perrigo confirms first to file patent challenge for Generic Version of Testosterone Gel 1.62% • Feb 15 Unimed Pharmaceuticals filed suit against Perrigo alleging

patent infringement, although Perrigo filed in Nov 2, 2011 • Sergeant’s Pet Care Products Unleashes Pronyl OTC® Flea and Tick

Spray for Dogs and Cats (the only generic to Frontline® Spray currently available)

PRGO Stock Price

Feb 16 – Mar 15

• $117.20 Mar 18 – Perrigo to begin shipments of Guaifenesin Extended-Release 600mg Tablets (first store brand equivalents to Mucinex® 600mg Extended Release Tablets)

• $118.25 Mar 22 – The Pomerantz Firm, Glancy Binkow & Goldberg LLP, and Robbins Geller Rudman & Dowd LLP announce the Notice of Proposed Settlement regarding the Perrigo Company Securities Litigation Settlement (misled investors regarding the Company’s exposure to at least $18M of Auction Rate Securities [fair value $14.5M] the impairment had an impact of ~$0.16 per share on net income)

• $118.87 Apr 1 – Perrigo closes acquisition of Companion Animal Health Company, Velcera, Inc.

• $120.78 Apr 2 – Perrigo Stock hits New 52 – Week High

PRGO Stock Price

Mar 16– Apr 11

Works Cited"Perrigo Co." msn MONEY. Microsoft. Web. 11 Apr 2013.

<http://investing.money.msn.com/investments/stock-price/?symbol=PRGO>.

"About Us." Perrigo. Perrigo Employees. Web. 11 Apr 2013. <http://www.perrigo.com/about/about-perrigo.asp&xgt;.

"Case - Perrigo Company." Pomerantz Law. eLawMarketing, 03 Mar 2013. Web. 11 Apr 2013. <http://www.pomerantzlaw.com/cases/perrigo-company>.

Any Questions?